Binx Health Stock

Binx Health is a health technology company that develops new approaches designed to diagnose and treat sexually transmitted infections (STIs). Their proprietary product is the Binx io point-of-care molecular platform, which aims to allow for rapid testing of chlamydia and gonorrhea. The platform can be used in various healthcare settings including doctor offices, urgent care facilities, and hospital emergency rooms, and strives to allow healthcare practitioners to deliver test results within 30 minutes with the goal of significantly reducing the amount of time between testing and diagnosis through traditional lab testing methods. Binx Health was founded in 2005 and is headquartered in Cambridge, MA.